A Patient-Derived Organoid Platform from TUR-P Samples Enables Precision Drug Screening in Advanced Prostate CancerZaukir Bostan Ali(Prince of Songkla University), Pasarat Khongkow(Prince of Songkla University)CancersDecember 12, 202510.3390/cancers17243973Cited by 2SaveCiteExport RISWatch citationsRelated PapersPaclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance|Oncogene|2015|248FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance|Oncogene|2013|133